Homeinvesting in healthcare mutual funds

investing in healthcare mutual funds

Travel & Leisure ETFs Set to Gain on COVID-19 Vaccine News

Travel & Leisure ETFs Set to Gain on COVID-19 Vaccine News

August 25, 2020

Novavax Begins Enrollment in Phase II Coronavirus Vaccine Study

Novavax Begins Enrollment in Phase II Coronavirus Vaccine Study

August 25, 2020

Editas’ SCD Candidate Gets FDA’s Rare Pediatric Disease Tag

Editas’ SCD Candidate Gets FDA’s Rare Pediatric Disease Tag

August 25, 2020

Stock Futures Mostly Higher on Trade Talks, Dow’s Shake-Up in Focus

Stock Futures Mostly Higher on Trade Talks, Dow’s Shake-Up in Focus

August 25, 2020

Bristol Myers to Buy Forbius to Boost Immunotherapy Pipeline

Bristol Myers to Buy Forbius to Boost Immunotherapy Pipeline

August 25, 2020

Merck’s Keytruda Gets Approval for Esophageal Cancer in Japan

Merck’s Keytruda Gets Approval for Esophageal Cancer in Japan

August 25, 2020

Exelixis Files for Cabometyx Combo in First-Line Kidney Cancer

Exelixis Files for Cabometyx Combo in First-Line Kidney Cancer

August 25, 2020

These Companies are Offering Hope for Parkinson’s Disease Patients

These Companies are Offering Hope for Parkinson’s Disease Patients

August 25, 2020

AbbVie Submits Regulatory Application to FDA for RINVOQ(TM) (upadacitinib) for the Treatment of Adults with Active Ankylosing Spondylitis

AbbVie Submits Regulatory Application to FDA for RINVOQ(TM) (upadacitinib) for the Treatment of Adults with Active Ankylosing Spondylitis

August 25, 2020

Morphic Announces that AbbVie Exercises License Option to ?v?6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases

Morphic Announces that AbbVie Exercises License Option to ?v?6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases

August 25, 2020

« 1 … 404 405 406 407 408 … 449 »